| 注册
首页|期刊导航|实用心脑肺血管病杂志|槲皮素治疗慢性阻塞性肺疾病的药理作用及机制研究进展

槲皮素治疗慢性阻塞性肺疾病的药理作用及机制研究进展

韩雪 许云鹏 陈明明 成慧昕 郭鸿 刘健

实用心脑肺血管病杂志2026,Vol.34Issue(3):25-31,7.
实用心脑肺血管病杂志2026,Vol.34Issue(3):25-31,7.DOI:10.12114/j.issn.1008-5971.2026.00.050

槲皮素治疗慢性阻塞性肺疾病的药理作用及机制研究进展

Research Progress on the Pharmacological Effects and Mechanisms of Quercetin in the Treatment of Chronic Obstructive Pulmonary Disease

韩雪 1许云鹏 1陈明明 1成慧昕 1郭鸿 2刘健1

作者信息

  • 1. 730000 甘肃省兰州市,兰州大学第一临床医学院
  • 2. 730000 甘肃省兰州市,甘肃省妇幼保健院 甘肃省中心医院
  • 折叠

摘要

Abstract

Chronic obstructive pulmonary disease(COPD)is a common respiratory disorder characterized by persistent airflow limitation and chronic inflammation,with no clinically available treatments capable of reversing the pathological damage.Quercetin,a natural flavonoid compound,exhibits multiple pharmacological activities such as antioxidant,anti-inflammatory,regulation of cellular homeostasis,and improvement of airway remodeling.This article systematically reviews the pharmacological effects and mechanisms of quercetin in the treatment of COPD,summarizes its synergistic effects in traditional Chinese herbal formulations,and highlights recent advances in the clinical translation of nanodelivery systems.The findings suggest that quercetin holds multi-target therapeutic potential for COPD.At present,the clinical application remains limited by poor solubility,low bioavailability,and insufficient stability.Future efforts should focus on structural modification,drug delivery system optimization,and multi-omics validation to advance its transformation into precision therapeutic strategies.

关键词

肺疾病,慢性阻塞性/槲皮素/药理作用分子作用机制/综述

Key words

Pulmonary disease,chronic obstructive/Quercetin/Molecular mechanisms of pharmacological action/Review

分类

医药卫生

引用本文复制引用

韩雪,许云鹏,陈明明,成慧昕,郭鸿,刘健..槲皮素治疗慢性阻塞性肺疾病的药理作用及机制研究进展[J].实用心脑肺血管病杂志,2026,34(3):25-31,7.

基金项目

国家自然科学基金资助项目(82460379) (82460379)

甘肃省联合科研基金重大项目(24JRRA934) (24JRRA934)

兰州大学"萃英科技创新"计划项目(CY2023-BJ-04) (CY2023-BJ-04)

实用心脑肺血管病杂志

1008-5971

访问量0
|
下载量0
段落导航相关论文